HF/Transplantation

Top Story

Enrollment begins for feasibility study of heart pump in patients with STEMI needing PCI

May 27, 2017

The first patients have been enrolled in an FDA-approved feasibility study to evaluate a heart pump for reduction of infarct size in patients with STEMI requiring PCI, according to a press release from Abiomed.

The study will assess the safety of the heart pump system (Impella CP, Abiomed) for unloading of the left ventricle prior to PCI in patients with STEMI without cardiogenic shock.

Meeting News

Obstructive sleep apnea could lead to atrial fibrillation

May 25, 2017
Patients with obstructive sleep apnea may be at greater risk for atrial fibrillation, according to findings recently presented at the American Thoracic Society…
FDA News

FDA designates recall of left ventricular assist device controller as Class 1

May 24, 2017
The FDA has designated Abbott/Thoratec’s product recall of a power supply for a left ventricular assist device pump as a Class 1 recall, the most serious kind. …
Meeting News

Wireless pacing system may confer long-term benefits in patients with HF

May 18, 2017
CHICAGO — Patients who had a wireless pacing system implanted to receive cardiac resynchronization therapy for the treatment of HF saw positive long-term results…

Enrollment begins for feasibility study of heart pump in patients with STEMI needing PCI

May 27, 2017
The first patients have been enrolled in an FDA-approved feasibility study to evaluate a heart pump for reduction of infarct size in patients with…

Meeting News

Obstructive sleep apnea could lead to atrial fibrillation

May 25, 2017
Patients with obstructive sleep apnea may be at greater risk for atrial fibrillation, according to findings recently presented at the American…

FDA News

FDA designates recall of left ventricular assist device controller as Class 1

May 24, 2017
The FDA has designated Abbott/Thoratec’s product recall of a power supply for a left ventricular assist device pump as a Class 1 recall, the…

Meeting News

Wireless pacing system may confer long-term benefits in patients with HF

May 18, 2017
CHICAGO — Patients who had a wireless pacing system implanted to receive cardiac resynchronization therapy for the treatment of HF saw positive…

FDA News

Three cardiac resynchronization therapy pacemakers approved to treat patients with heart failure

May 10, 2017
The FDA has approved three quadripolar cardiac resynchronization therapy pacemakers for the treatment of patients with HF, Medtronic announced. With…

Meeting News

Patients implanted with VAD via thoracotomy may have improved outcomes

May 10, 2017
Patients with end-stage HF who have had a ventricular assist device implanted by thoracotomy procedure were alive and did not have adverse events at…

Meeting News

EDIFY: Ivabradine fails to improve outcomes in HFpEF

May 10, 2017
In individuals with HF with preserved ejection fraction, heart rate reduction with ivabradine did not improve outcomes, according to findings from…

FDA News

FDA approves line of ICDs, CRT-Ds for patients with heart failure

May 9, 2017
Boston Scientific announced that the FDA has approved its new line of implantable cardioverter defibrillators and cardiac resynchronization therapy…

Meeting News

Beta-blockers reduce mortality in HFrEF with sinus rhythm

May 9, 2017
Beta-blockers reduced mortality in individuals with HF with reduced ejection fraction in sinus rhythm regardless of pretreatment heart rate…

Trial Scorecards

Trial Scorecard: RESET-HCM

Cardiology Today, May 2017
Researchers evaluated the effect of moderate-intensity exercise training on patients with hypertrophic cardiomyopathy.

More Headlines »
Advertisement
Advertisement